Artificial Intelligence and the Future of Cancer Care

Artificial intelligence (AI) is rapidly changing how our world solves complex challenges, and cancer is no exception. Eliezer Van Allen, MD, facilitates a discussion with leading researchers on how Dana-Farber is harnessing the power of AI to better understand and treat cancer in its many forms. Presenters highlight successes, challenges, and the promise that AI holds for the future of cancer care. Panelists include Andrew Hantel, MD, Charlotta Lindvall, MD, PhD, and Bill Lotter, PhD.

Give Now

Thank you for your interest in learning more about The Dana-Farber Campaign. You have been added to our email list and will receive updates on ways to join us in defying cancer. You can unsubscribe at any time.

There has been an issue submitting your request. Please try again.

Founded in Boston in 1947, Dana-Farber is a principal teaching affiliate of Harvard Medical School and a federally designated Comprehensive Cancer Center that develops and disseminates innovative patient therapies and scientific discoveries throughout the world. About Our Patient Stories: Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.

At Dana-Farber we are committed to an inclusive community where human differences are valued and celebrated, and where all are welcome. We work every day to create an innovative, caring, and inclusive environment where each patient, family, and staff member feels valued and respected.